iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials

March 21, 2019 10:11 AM EDT

iShares Nasdaq Biotechnology (NASDAQ: IBB) March weekly call option implied volatility is at 24, April is at 20; compared to its 52-week range of 15 to 40 after Biogen (BIIB) discontinues two Alzheimer's trials. Call put ratio 1 call to 3.3 puts with focus on June 100 puts.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Options